S&P 500 7,631.47 -0.71%Nasdaq 26,099.77 -1.03%Dow 52,766.88 -0.79%Russell 2000 2,920.13 -1.23%as of 2026-09-01 close
The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd
Market Pulse

Edible Garden Regains Nasdaq $1.00 Bid-Price Compliance; the Hearings Panel Keeps Jurisdiction Through Nov. 23

The controlled-environment agriculture company said on Sept. 2 that Nasdaq had confirmed it has regained compliance with the $1.00 minimum closing bid price rule. The company said in July that its closing bid price had stayed at or above $1.00 since a 1-for-45 reverse split took effect on July 13, and the Panel that granted continued listing retains jurisdiction through Nov. 23.
Illustrative photograph: stock-market trading screens showing price charts.

Edible Garden AG Incorporated (Nasdaq: EDBL, EDBLW) said in a release issued at 07:28 ET on Sept. 2, 2026 that it had received a letter from Nasdaq confirming it has regained compliance with Listing Rule 5550(a)(2), the requirement to maintain a minimum closing bid price of $1.00 per share. The confirmation follows the decision of a Nasdaq Hearings Panel that the company announced on July 28, 2026.

The company effected a 1-for-45 reverse stock split with an effective date of July 13, 2026. In its July 28 announcement it said that since the reverse stock split became effective, the closing bid price of its common stock had remained at or above $1.00 per share. A reverse split raises the quoted price arithmetically by reducing the share count; it does not by itself alter revenue, cash, losses or the underlying demand for the shares. Neither release the Herald reviewed attributes the regained compliance to any change in the operating business.

The Panel has not finished with the company

The July 28 announcement set out the terms on which continued listing was granted. The Panel granted the company's request for continued listing contingent on demonstrating compliance with Rule 5550(a)(2) by Aug. 15, 2026, and stated that it would maintain jurisdiction over the company's listing through Nov. 23, 2026. That monitoring period is still running. Regaining bid-price compliance closes one condition; it does not end the Panel's jurisdiction, which on the company's own account extends through Nov. 23.

Two details in the Sept. 2 release are worth noting for what they omit. The release does not state the number of consecutive business days over which the closing bid price was at or above $1.00, nor the specific date range Nasdaq relied on. It also does not explain the interval between the Panel's stated Aug. 15 compliance deadline and the Sept. 2 date of the confirmation letter. The Herald reports both dates as the company stated them and draws no inference from the gap.

The financial picture behind the listing

The figures below are taken from the company's second-quarter results release of Aug. 14, 2026, covering the three and six months ended June 30, 2026. They are roughly two months old, they predate the Sept. 2 compliance confirmation, and they do not reflect any financing, spending or share issuance since the balance sheet date. The release presented no adjusted EBITDA or other non-GAAP measure; the figures are as the release presented them.

For the second quarter the company reported revenue of $3.6m against $3.1m a year earlier, which the release headlined as a 12.8% increase, with gross profit of $0.6m in both periods and a net loss of $3.3m against $4.0m. For the six months it reported revenue of $6.9m against $5.9m and a net loss of $6.9m against $7.4m. The Herald reports these at the level of precision the release presented and has not reconciled them to the financial statements in the corresponding SEC filing.

The same release reported cash and cash equivalents of $658,000 as of June 30, 2026, and 525,638 shares of common stock outstanding as of that date, a figure the company footnoted as adjusted to reflect the stock splits. Both are stated here as reported. The Herald draws no conclusion about liquidity, runway or solvency from the cash figure, and readers should not read one into its inclusion.

The Herald did not retrieve and review the corresponding quarterly report on Form 10-Q for this article, and therefore makes no statement about whether that filing contains going-concern language or a specific liquidity disclosure. The Aug. 14 results release the Herald did review contained no going-concern or substantial-doubt language. Readers who want that assessment should consult the filing itself rather than infer it from the figures above.

In the Sept. 2 release, chief executive Jim Kras described regaining compliance as an important development for the company and said it allows Edible Garden to keep its focus on executing its growth strategy. In the July 28 announcement he indicated the company's attention was on its Webster City facility and on cost reduction initiatives. Both characterisations are the company's own and are reported here in indirect speech.

Micro-cap and nano-cap securities carry substantial risk, including the possible total loss of an investment. Liquidity is frequently thin and a quoted price may not be obtainable in any meaningful size, a point that applies with particular force to a company with a share count in the hundreds of thousands following a 1-for-45 consolidation. Compliance with one continued listing standard does not establish compliance with the others, and a company under Hearings Panel jurisdiction remains subject to that Panel's conditions.

The Herald does not offer investment advice, does not publish price targets, and takes no view on whether this security should be bought or sold. The dates on the record are Nov. 23, 2026, when the Panel's stated jurisdiction runs to, and July 13, 2026, when the reverse split that produced the compliant bid price took effect.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage

Illustrative photograph: stock-market trading screens showing price charts.
Market Pulse

Four Nasdaq companies disclosed late-filing deficiencies in nine days, and the cure clocks run to very different places

Gulf Resources, Breeze Acquisition Corp. II, Shuttle Pharmaceuticals and Netcapital each told investors in the second half of August that Nasdaq had cited them under Listing Rule 5250(c)(1) for overdue periodic reports. The rule is the same in each case; the deadlines the four companies disclosed range from this Monday to February 2027.

Kwame Osei · August 31, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Market Pulse

Four Micro-Cap Consolidations Across Three Sessions Cut Vision Marine to About 653,000 Shares and Longeveron to About 3.0 Million Class A

Vision Marine, Longeveron and Cycurion each moved this week to consolidate shares and defend a Nasdaq listing. A fourth, OTCQB-quoted GlobalTech, split to try to obtain one. All four left authorized share counts untouched.

Kwame Osei · August 27, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Market Pulse

Three Reverse Splits Hit the Nasdaq Tape Friday Morning. The market-value rule that would matter most to the companies behind them was approved on July 22, automatically stayed on July 29 and is not in force today.

PMGC Holdings consolidated 1-for-10 at midnight Friday, taking roughly 8.1 million shares to about 809,584; Bit Origin went 1-for-5 at the open and Smartkem 1-for-50 after Thursday's close. None of it moves market value — and a Nasdaq rule approved July 22 that would delist companies below $5 million of market value with no cure period was automatically stayed a week later pending full Commission review.

Kwame Osei · August 21, 2026